These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 21830278)
1. Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers. Olaru AV; Cheng Y; Agarwal R; Yang J; David S; Abraham JM; Yu W; Kwon JH; Lazarev M; Brant SR; Marohn MR; Hutcheon DF; Harpaz N; Meltzer SJ; Mori Y Inflamm Bowel Dis; 2012 Apr; 18(4):641-8. PubMed ID: 21830278 [TBL] [Abstract][Full Text] [Related]
2. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. Nagasaka T; Koi M; Kloor M; Gebert J; Vilkin A; Nishida N; Shin SK; Sasamoto H; Tanaka N; Matsubara N; Boland CR; Goel A Gastroenterology; 2008 Jun; 134(7):1950-60, 1960.e1. PubMed ID: 18435933 [TBL] [Abstract][Full Text] [Related]
3. Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers. An B; Kondo Y; Okamoto Y; Shinjo K; Kanemitsu Y; Komori K; Hirai T; Sawaki A; Tajika M; Nakamura T; Yamao K; Yatabe Y; Fujii M; Murakami H; Osada H; Tani T; Matsuo K; Shen L; Issa JP; Sekido Y Int J Cancer; 2010 Nov; 127(9):2095-105. PubMed ID: 20131317 [TBL] [Abstract][Full Text] [Related]
4. Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype. Gebhard C; Mulet-Lazaro R; Glatz D; Schwarzfischer-Pfeilschifter L; Schirmacher P; Gaedcke J; Weichert W; Reuschel E; Dietmaier W; Rehli M Int J Cancer; 2022 Feb; 150(4):617-625. PubMed ID: 34591983 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. Ang PW; Loh M; Liem N; Lim PL; Grieu F; Vaithilingam A; Platell C; Yong WP; Iacopetta B; Soong R BMC Cancer; 2010 May; 10():227. PubMed ID: 20492682 [TBL] [Abstract][Full Text] [Related]
6. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels. Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226 [TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. Kim JH; Shin SH; Kwon HJ; Cho NY; Kang GH Virchows Arch; 2009 Dec; 455(6):485-94. PubMed ID: 19911194 [TBL] [Abstract][Full Text] [Related]
8. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers? Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. Nosho K; Irahara N; Shima K; Kure S; Kirkner GJ; Schernhammer ES; Hazra A; Hunter DJ; Quackenbush J; Spiegelman D; Giovannucci EL; Fuchs CS; Ogino S PLoS One; 2008; 3(11):e3698. PubMed ID: 19002263 [TBL] [Abstract][Full Text] [Related]
11. Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer. Tanaka N; Huttenhower C; Nosho K; Baba Y; Shima K; Quackenbush J; Haigis KM; Giovannucci E; Fuchs CS; Ogino S Am J Pathol; 2010 Dec; 177(6):2731-40. PubMed ID: 21037082 [TBL] [Abstract][Full Text] [Related]
13. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Hinoue T; Weisenberger DJ; Lange CP; Shen H; Byun HM; Van Den Berg D; Malik S; Pan F; Noushmehr H; van Dijk CM; Tollenaar RA; Laird PW Genome Res; 2012 Feb; 22(2):271-82. PubMed ID: 21659424 [TBL] [Abstract][Full Text] [Related]
14. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Kim JH; Bae JM; Cho NY; Kang GH Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113 [TBL] [Abstract][Full Text] [Related]
15. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180 [TBL] [Abstract][Full Text] [Related]
16. Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators. Tahara T; Yamamoto E; Madireddi P; Suzuki H; Maruyama R; Chung W; Garriga J; Jelinek J; Yamano HO; Sugai T; Kondo Y; Toyota M; Issa JP; Estécio MR Gastroenterology; 2014 Feb; 146(2):530-38.e5. PubMed ID: 24211491 [TBL] [Abstract][Full Text] [Related]
17. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer. Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637 [TBL] [Abstract][Full Text] [Related]
18. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942 [TBL] [Abstract][Full Text] [Related]
19. Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype. Yamamoto E; Suzuki H; Yamano HO; Maruyama R; Nojima M; Kamimae S; Sawada T; Ashida M; Yoshikawa K; Kimura T; Takagi R; Harada T; Suzuki R; Sato A; Kai M; Sasaki Y; Tokino T; Sugai T; Imai K; Shinomura Y; Toyota M Am J Pathol; 2012 Nov; 181(5):1847-61. PubMed ID: 22995252 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features. Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]